Efectividad y seguridad del sistema Urolift® para el tratamiento de los síntomas de la hiperplasia benigna de próstata: revisión sistemática

Although the quality of evidence is low, Urolift® constitutes a good therapeutic alternative for patients with benign prostate hyperplasia. The short to medium-term results show that the technique contributes to improving lower urinary tract symptoms, with no relevant side effects, does not affect sexual function and improves quality of life. Further research is required, especially on long-term results.